Aristo Bio-Tech And Lifescience Limited — Others, 29-05-2025: Cessation

Aristo Bio-Tech and Lifescience Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company reported total revenue of ₹318.55 Cr for the year ended March 31, 2025, with profit before tax of ₹5.47 Cr and net profit of ₹4.06 Cr, up from ₹3.90 Cr the previous year. The board proposed a final dividend of ₹0.50 per share, subject to shareholder approval. Mrs. Ayushi Aditya Deora resigned as Company Secretary & Compliance Officer, replaced by Ms. Diksha Jaiprakash Peswani. The audit report is unqualified.